Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Twitter
  • LinkedIn
  • Instagram
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Get Involved
    Stories View All
    View All
    Explore Somatic Biomarker Testing Report Component Biomarker Testing
    Clinical practice
    Learn How to Read a Somatic Biomarker Testing Report
    October 06, 2023
    Learn How to Conduct Mock Code Simulations
    Clinical practice
    Learn How to Conduct Mock Code Simulations
    August 18, 2023
    Nurse-Led QI Project Standardizes Transplant and Cellular Therapy Nurse Coordinator Visit Scheduling
    Quality of care
    Nurse Practitioner's QI Project Standardizes Transplant and Cellular Therapy Nurse Coordinator Visit Scheduling
    August 03, 2023
    Nurse-Created Apps Help Pediatric Patients Find Their Voice and Navigate Their Cancer Journey
    Patient Support
    Nurse-Created Apps Help Pediatric Patients Find Their Voice and Navigate Their Cancer Journey
    July 21, 2023
    Certification Was a Critical Step Along My Oncology Nursing Career Journey
    Oncology nursing community
    Certification Was a Critical Step Along My Oncology Nursing Career Journey
    July 14, 2023
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Chemotherapy

    Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil

    Doxorubicin is a cytotoxic chemotherapy drug and an antitumor antibiotic in the anthracycline group. You’ll see this drug quite a lot In the outpatient setting, and most commonly, you’ll use it to treat patients with breast cancer.
    April 10, 2015
    Cancer treatments

    Outpatient Oncology Drug Series: Don't Forget Leucovorin Calcium, the Superhero Sidekick

    I think it's helpful to be able to educate your patients on the reasons for receiving each individual drug in a combination regimen. Although leucovorin is not a chemotherapy agent or generally used as a stand-alone drug, it certainly is important. Leucovorin has a specific function, and you should be able to explain its purpose.
    March 16, 2015
    Cancer treatments

    Outpatient Oncology Drug Series: Confidently Administer 5-Fluorouracil

    5-Fluorouracil, or more commonly referred to as simply 5-FU, is a cytotoxic chemotherapy drug that is classified as an antimetabolite and, within that class, belongs to the pyrimidine analogue family.
    February 23, 2015
    Chemotherapy

    Outpatient Oncology Drug Series: Oxaliplatin Hates the Cold

    Oxaliplatin is a cytotoxic (toxic to normal cells) chemotherapy drug that is classified as an alkylating agent as well as a platinum analogue. It is indicated for a number of different cancers including colorectal, esophageal, gastric, hepatobiliary, Non-Hodgkin lymphoma, ovarian, pancreatic, and testicular cancer.
    January 16, 2015
    Chemotherapy

    Outpatient Oncology Drug Series: Paclitaxel Packs a Punch

    Oncology nursing is a field in which you are challenged on a regular basis to expand your knowledge because of the constantly changing field of treatments being used. Whether you are new or seasoned, it can be difficult to stay on top of the numerous agents used for varying diagnoses.
    December 12, 2014

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Jill Weberding BSN, MPH, RN, OCN®
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Twitter
  • LinkedIn
  • Instagram
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲